Arginine mimetics as factor X a inhibitors

Details Arginine mimetics as factor X a inhibitors Arginine mimetics as factor X a inhibitors

2006-05-02

2006-05-02

Richter, Johann (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acid esters

C560S173000, C564S123000, C564S148000, C564S149000, C564S152000, C564S153000

Reexamination Certificate

active

07038074

ABSTRACT:
The invention relates generally to a novel type of arginine mimetics which are inhibitors of factor Xa; to pharmaceutical compositions which comprise these mimetics; and to the use of these arginine mimetics for producing compositions for antithrombotic therapy.

REFERENCES:
patent: 25 40 134 (1976-03-01), None
patent: 0 097 630 (1984-01-01), None
patent: 0 513 675 (1992-11-01), None
patent: 513675 (1992-11-01), None
patent: 9417035 (1994-08-01), None
patent: WO 94 23758 (1994-10-01), None
Sperl et al., Biol. Chem. 381 321-329.
Journal of Enzyme Inhibition (1995), 9(1), 87-99 (Chemical Abstracts online abstract [retrieved on Nov. 18, 2005] Columbus OH, USA).
Stefan Sperl et al.: “Urethanyl-3-Amidinophenylalanine Derivatives as Inhibitors of Factor Xa. X-Ray Crystal Structure of a Trypsin/Inhibitor Complex and Modeling Studies” Biological Chemistry, vol. 381, Apr. 2000, pp. 321-329, XP001002861.
Torsten Steinmetzer et al.: “Pept. Proc. Am. Pept. Sym. 15th; A Novel Approach for SPPS of Compounds with an Amidino Group in the C-terminal Residue Using Trityl Resins” 1999, Kluwer, Dordrecht, NL XP001002826; p. 261, col. 262.
Markus Böhm et al.: “Three-Dimensional Quantitative Structure-Activity Relationship Analysis Using Comparative Molecular Field analysis and Comparative Molecular Similarity Indices Analysis to Elucidate Selectivity Differences of Inhibitors Binding to Trypsin, Thrombin, and Factor Xa” Journal of Medicinal Chemistry., vol. 42, 1999, pp. 458-477, XP002169712 American Chemical Society, Washington., US; ISSN 0022-2623; p. 464, col. 1, line 1.
B. Voigt et al.: “Synthese von N-alpha-Benzyloxcarbonyl-4-amidinophenyla laninamiden als thrombininhibitoren” Pharmazie., vol. 40, No. 5, 1985, pp. 305-306, XP002169713; Berlin DD.
J. Stürzebecher et al.: “Synthetische Inhibitoren der Serinproteasen” Pharmazie., vol. 42, No. 2, 1987, pp. 114-116, XP002169714 Veb Verlag Volk Und Gesundheit, Berlin., DD ISSN: 0031-7144 tables 1-3.
Hideaki Tsunematsu et al.: “A New beta-Naphthylamide Substrate of p-Guanidino-L-Phenylalanine for Trypsin and Related Enzymes” Journal of Biochemistry., vol. 98, No. 6, Dec. 1985, pp. 1597-1602, XP002169715 Japanese Biochemical Society, Tokyo., JP ISSN: 0021-924X; p. 1598, col. 1, line 17-line 18.
R. Alan Chrusciel et al.: “4-Acetamidophenyl Esters and 4-Acetamindoanilides of L-Arginine, p-Guanidino-L-phenylalanine, L-Lysine, N2-′D-Fructos-3-0-yl and D-Glucos-3-0-yl l acetyl-L-lysine as Potential Acrosin Inhibitors” Tetrahedron, (INCL Tetrahedron Reports), vol. 47, No. 42, 21 Oxford GB; p. 8848, line 22-line 32; table A.
Daniel A. Pearson et al.: “Thrombus Imaging Using Techneticum-99m-Labeled High-potency GPIIB/IIIa Receptor Antagonists. Chemistry and Initial Biological Studies” Journal of Medicinal Chemistry., vol. 39, No. 7, 1996, pp. 1372-1382, XP002169717; American Chemical Society, Washington, US ISSN: 0022-2623; seite 1375, Schema 5, Verbindung 28; Seite 1380, Spalte 2, Zeile 42-Zeile 63.
Yusuke Sasaki et al.: “Studies on Analgesic Oligopeptides. II. Structure-Activity Relationship among Thirty Analogs of a Cyclic Dipeptide, Cycly (-Tyr-Arg-)” Chemical and Pharmaceutical Bulletin., vol. 30, No. 12, Dec. 1982, pp. 4435-4443, XP002169718 Pharmaceutical Society of Japan, Tokyo, JP ISSN: 0022-2623; p. 4441, line 3-line 13.

Affiliated with

Also associated with

Rating

Arginine mimetics as factor X a inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arginine mimetics as factor X a inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arginine mimetics as factor X a inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3651237